I HAVE chosen the subject of the treatment of gout for the following reasons: First, there is an impression that gout has become a rare disease, wlhereas I believe that, although much less common than it used to be, it still occurs fairly frequently. During the last two years I myself have seen ten cases in the Out-patient Department at St. Bartholomew's Hospital. Some of these patients were in the middle of an acute attack, but the majority had been ill for a long time, an(d were suffering from a chronic joint trouble which had usually been diagnosed as rhIeumatoid arthritis. Secondly, because of the improvement in the condition which has taken place as a result of treatment with cinchophen. Thirdly, because of some unpleasant symptoms which have occurred after cinchophen has been given.
DIAGNOSIS.
Before I speak of the details of treatment I must discuss the diagnosis of the condition.
(1) The family history is of very great value, since a history of typical attacks of gout in other members of the family make it probable that an atypical joint lesion is due to gout. (2) The actual history of the first joint symptoms in a chronic case is of great value. The first attack may be a typical one, involving the big-toe joint, altlhough the subsequent attacks may only affect the hands or knees. ( 3) The diagnosis of gout is easily made clinically when the big-toe is affected and also when the carpo-metacarpal joints of the index and ring fingers of the hands are involved; but it is much more difficult when the knees, ankles, wrists or shoulders are affected.
(4) The shape of the joints is nearly always asymmetrical and this point is of use in making the diagnosis from subacute infective arthritis, where the joints are uniformly swollen. (5) The presence of tophi in the ears, or swellings of the bursae, are of great assistance, but they do not often occur. (6) The changes which take place in tho bones due to the deposit of sodium biurate make the skiagram of great value itn the diagnosis. Sodium biurate, unlike a calcium salt, is not opaque to the X-rays, and when sufficient calcium has been displaced by sodium biurate, a clear area will be seen in the plate. These changes are very obvious in the long-standing cases, but are rarely seen after only one attack. The changes are best seen in the small bones of the hands and feet, whereas it is rare to detect the changes in a knee-joint, because of the great thickness of the bone. I have never seen typical changes in a knee-joint and only once in a shoulderor hip-joint. Phillips, Pomeranz and Pincus [1] , in an analysis of 100 cases, saw typical changes in one knee-joint, three hip-joints and ten shoulder-joints. Fig. 1 (p. 2) shows the changes in a case of moderate severity.
The changes in the bones must be distinguished from three other conditions.
In the skin disease, lupus pernio, changes occur in the bones which are identical witlh those of gout. In the arthritis which occurs in association with psoriasis the changes are suggestive of gout. One such case I saw with Dr. Geoffrey Evans and thought was due to gout because the skiagram showed some small punched-out areas in the terminal phalanges. It was not until psoriasis of the nails developed that the correct diagnosis was made.
I have been shown the skiagrams from a case of multiple enchondromata of one hand in which the appearances did resemble those of very severe gout but the clinical appearances were quite unlike those of gout (Mr. J. P. Ross, F.R.C.S.). Further, the changes must be distifiguished from those due to a long-standing subacute infective arthritis. In these cases there is a general loss of calcium and the bones do not cast a good shadow, but no punched-out areas occur. (6) The estimation of the uric acid in the blood is sometimes of great assistance in a doubtful case. In normal persons the uric acid is usually below 3 mgm. per 100 c.c. of blood, but it is raised in certain diseases. If a patient is suffering from a chronic nephritis with urea retention the uric acid is always increased. If the patient has a leukaemia, the blood uric acid is also increased. There are also a certain number of people whose blood uric acid is over 3 mgm. per cent. although they have never had an attack of gout. Still, it is probable that if the patient has a joint lesion and a raised blood uric acid, the condition is due to gout. Unfortunately some patients with typical gout do not have raised blood uric acid. Folin [2] watched such a patient and found that the blood uric acid increased when the attack was coming on. Gudzent [3] has found that the blood uric acid was low in 30 per cent. of his cases of gout and he has also observed that the uric acid increased before an attack. It follows that a high figure for the blood uric acid is strongly in favour of gout while a low -one does not negative the diagnosis.
TREATMENT.
The treatment of gout may be divided into: (1) Treatment of the acute attack; (2) prevention of the attacks; (3) treatment of the chronic joint lesion.
(1) Treatment of the Acute Attack. The first essential in the treatment of the acute attack is that the patient shall rest the limb in question properly. If the attack is severe, there is no difficulty about this, but if it is not very severe many patients want to keep about and continue their work. If the lower limb is affected rest in bed is indicated, but if the upper limb is involved, it is usually sufficient to put it in a sling with or without a splint. If the patient is in bed, a cradle must be used to take the weight of the bedclothes off the toes. Local applicatiohs, like lotio plumbi, help to relieve the pain. The drug which acts best is colchicum, either the tincture or the vinum. This should be given in a dose of either 15 to 20 minims every four or eight hours as soon as the attack commences. The active principle of colchicum, colchicine, in doses of -r to 'u gr., is said to give good results, though I have not used it myself. I know of two men who always carry about a colchicum preparation, when travelling, so that it can be taken as soon as an attack starts, a delay of some hours thus being avoided. The mode of action of colchicum is not understood. It has no effect on the excretion of uric acid but it certainly relieves the pain and cuts short the attack. Although colchicum is so potent, it is of no value in preventing attacks. It possesses the somewhat serious disadvantage of causing unpleasant symptoms. There may be only one symptom, namely, pain after meals, but the taking of colchicum, if persisted in, may set up a more severe dyspepsia. Sometimes it will cause diarrhcea. A man, to whom I shall refer later, who has great destruction of the bones, can never take colchicum at all as he vomits at once. On one occasion I gave him a preparation of cinchophen which contained some colchicine. He vomited the next meal and stated that he had been given colchicum. Cinchophen is also of value in the acute attack, but I will speak of its action later on.
In the prevention of the attack, diet plays a great part. In the past, the dietetic restrictions have been very severe, so, severe that it was difficult for the patient to continue treatment, but at the present day it is much more lenient. The most important one is the abstinence from all foods which contain large amounts of nucleoproteins, which are the precursors of uric acid, that is, the avoidance of all gland organs like sweet-breads, kidney and liver. Meat and fish do contain purins but in much less quantity. Beef contains more than mutton or game, and if it is desired to make the diet very strict, this should be avoided. More important is the reduction in the total protein, which should not exceed 60 to 80 grm. per diem, corresponding to 10 to 12 grm. of nitrogen. One of the recommendations of the past was the avoidance of sugar, although starch was permitted in bulk. It is difficult to understand this recommendation, unless the patient also has a low sugar tolerance. Tea and coffee, which were once forbidden, are now usually allowed. The total caloric requirements must be sufficient for the patient's normal activities and to maintain weight. Although gout is usually associated with overeating in general, it does occur in thin, spare people. Alcohol in various forms is, undeniably, a contributory cause of gout, though its mode of action is quite unknown. Widal and his co-workers [4] have found that patients with gout will often give skin reactions when tested out with different wines. Of nineteen cases, three gave very intense reactions, thirteen feeble ones and three none at all. Of the controls, twenty-eight gave negative tests, two gave positive tests with several wines and three with only one wine. One lady, who gave an intense skin reaction with burgundy, always had an attack of gout after drinking it. Widal could not discover what made burgundy so potent when the wine from a neighbouring district caused no symptoms. The red wines of Burgundy were the most potent, and, curiously enough, port wine, which has the worst reputation in England, did not give any skin reactions. Beer and champagne are both considered to be very potent in this country. Spirits do not affect the patients. The general health must be cared for and all sources of sepsis,teeth, tonsils, &c.-should receive the same careful attention which they do in any disease.
(2-3) Prevention of the Attacks and Treatment of the Chronic Joint Lesion.
In the prevention of the attack and in relieving the chronic joint condition the drug which is most valuable is cinchophen, which is sold in England under the various proprietary names, atophan, agotan, phenoquin, quinophan. This substance, first made in 1887, has the formula cm coom cm COO and is a derivative of quinoline, 2 phenyl, 4 carboxylic acid.
In the United States of America, the laboratory of the American Medical
Association L5] has carried out an analysis of the different preparations of cinchophen made by six different firms and found that they were all equally pure. The price, however, varied from 17/6 to 3/6 per 50 grm. In this country the preparations have not been tested by any central laboratory. The price varies from 15/to 6/6 per 50 grm.
It was introduced into medicine by Nicolaier and Dohrn [6] , whio showed that it caused a great increase in the output of uric acid in the urine of healthy persons but especially in patients with gout. There has been, and still is, a dispute about its mode of action. Some workers have thought that it increases the purin metabolism and so causes a greater output of uric acid, whereas others have thought that it enables the kidney to excrete more uric acid. A great advance was made in this dispute when Folin [7] introduced a relatively simple method of estimating the uric acid in the blood. Folin and Lyman [8] thought that the "extra " uric acid in the urine came from the blood, but a calculation of the total amount of uric acid in the blood showed that this could onily supply about one-tenth of the uric acid excreted in the urine. I made a communication on this point to this Section in 1920 [9].
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The patient was under the care of Sir Archibald Garrod in the ward of the Medical Unit at St. Bartholomew's Hospital. He had very severe gout; the bones of the hands had been largely destroyed by deposits of sodium biurate and two fingers had been amputated in 1915. He had abundant deposits of sodium biurate elsewhere in the body. He was given a purin-free diet and after a control period was given 20 gr. of cinchophen, three times a day for four days. The uric acid output in the control period was about 0 22 grm., instead of the usual 0 5 to 0 * 7 grm. The blood uric acid was 4*5 mgm., but this was estimated by Folin's old method which gave somewhat lower results than the new methods (Benedict [22], Folin [23] ). The increase in the uric acid output was very striking, as it rose to 0 * 58 grm. on the first day and fell to 0 45 grm. on the third day. On the fifth day it rose again to 0 * 75 grm. although the cinchophen had been stopped, and then rapidly to 0 * 30 grm. per day and remained constant, about 0. 1 grm. higher than in the control period ( fig. 2) . The blood uric acid fell to 2 9 mgm. per cent. on the fourth day. The extra uric acid excreted in the three days was 0 84 grm. and in the next three days 1 * 06 grm., so that the man excreted 2 * 9 grin. more uric acid in six days than in the control period. The total uric acid in the blood before the experiment was 018 grm. and after the third day was 0 116 grm., a loss of only 0 064 grm. in contrast with 0 * 84 grm. in the urine. Except for the cerebro-spinal fluid and the muscles, the organs contained almost the same amount as the blood. The muscles in one case contained a large amount of uric acid. I therefore calculated the amount which would be present in the body fluids of this patient. Before the cinchophen was given it was 2411 grm. and on the fourth day it had fallen to 1 36 grm. This was a loss of 0 * 75 grm. as compared with the 0-84 grm. of " extra " uric acid excreted in the urine. In a second experiment ( fig. 3) , the " extra " uric acid was 0 63 grm., whereas the apparent loss from the body fluids was 1 0 grm.
It is unreasonable to expect that the figures obtained by these calculations should agree exactly, but they serve to show that the body fluids probably contain sufficient sodium biurate to supply the " extra " uric acid excreted in the urine, after cinchophen.
The uric acid begins to re-accumulate in the blood, and therefore presumably in the tissues, as soon as the cinchophen administration is discontinued. [12] found that the uric acid had reached its original level after twenty-four hours. In one of my experiments the blood uric acid had increased from 2 to 4 mgm. per cent. on the third day ( fig. 4, page 7) . The source of this uric acid is more difficult to be certain about. It cannot be due to a failure of excretion as the amount of uric acid excreted in the urine remained high. It could be due to increased formation, but of this there is no evidence. The other source is the sodium biurate in the bones and elsewhere. In the case of my patient there are ample supplies, and in the course of the six years of treatment I think that the swellings have become definitely smaller, but unfortunately no plaster casts were made. The tophi in the ears and hands have considerably decreased in size and number.
In the light of these observations it would seem that the cinchophen enables the body to rid itself of uric acid and it seems probable that the "extra" uric acid excreted comes at first from the blood and tissue fluids and subsequently from the sodium biurate which has already been deposited. Whatever views may be held about the relation of uric acid to gout, it cannot be good for a patient to store up uric acid in his body, and on this hypothetical ground alone, I would advocate the giving of cinchophen.
In view of the discovery that cinchophen only caused a large increase of uric acid for the first two or three days of its administration and that it then fell to normal, it was suggested that it was only necessary to give it for three-day periods and then to allow a period in which no drugs are given before beginning another course. I adopted this principle and have treated all my gout cases on these lines:
The man in question has had einchophen for the last six and a half years in 20 gr. doses three times a day for three consecutive days in each week. During this period his health has steadily improved, whereas in the previous five years it had become steadily worse. He has only had one attack of gout and on that occasion a mass of sodium biurate, which weighed 35 grm. when wet, was removed by himself from a sinus over the knee. He has never had any massage or radiant heat, both of which are most useful in the treatment of the chronic joint condition, as his hands were too damaged to recover any movement. After some months he said that the state of his knees and ankles was improving and that ne was able to walk about much better. I have treated many otber patients on these lines in the last sixyears and -the great majority have had no acute attacks during this period, and the local condition has improved considerably. One patient, however, had an attack of gout immediately after taking cinchophen on two occasions, and Dr. A. G. Evans has noticed this in one other patient.
Cinchophen is not the only drug which causes an increase in the output of uric acid. Both sodium salicylate and sodium benzoate possess this property. Denis [131 showed that after 100 gr. of sodium salicylate, the excretion was as good as after cinchophen, but a dose of 45 gr. had very little effect. The disadvantage of ordering sodium salicylate for intermittent administration in a dose of 100 gr. a day is that the patient is conscious of its effects, whereas cinchophen causes no symptoms unless it is not tolerated (see later, p. 8).
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Cinchophen is also used for other purposes in medicine. It is of use in the treatment of acute rheumatism and relieves the pain just as effectively as sodium salicylate (Hanzlik [14] ). It is also used in the treatment of patients with infective arthritis and relieves the pain considerably. It has a considerable effect on the liver and has been used for the treatment of catarrhal jaundice aud the jaundice which occurs in new-born children [15 . Brusch and Horsters [161 have made some interesting observations on a patient with a biliary fistula. They found that cinchophen caused an increase in the volume, in the dry solids, and also in the amount of bile pigment. They investigated various other compounds of a similar nature and found that cinchophen was the only one which had this property although desoxycholic acid acted nearly as well.
Before Nicolaier and Dohrn [6] introduced cinchophen into clinical medicine they had tested its action on animals and had not observed any evil effects. As it has been used more and more, a certain number of unpleasant after-effects have been noticed. Most of these are not serious, e.g., malaise and headache while it is being taken, gastro-intestinal symptoms such as pain and discomfort after meals on those days on which it is taken, urticaria and sometimes albuminuria. No serious complication was described until 1924, when Worster-Drought [17] described a case in which urticaria was followed by a mild attack of jaundice which lasted for some six weeks. In July of 1926, Langdon Brown [18] reported that two patients had developed jaundice and died. Sir William Willcox [191 had also seen three cases of jaundice. One patient who had only taken 15 gr. a day for one week died after being ill for twenty-eight days but the other two patients recovered. C. Wells [20] has recorded the death of a woman who had been taking cinchophen.
A. G. Evans [21] reported three cases in which a mild jaundice had occurred, and L. G. Glover [22] described a case in which jaundice had followed the injection of atophanyl, although two previous injections had been given in Germany without any untoward results. With Dr. Langdon Brown's permission I have examined the notes of his two cases:-Case1.-Patient, a woman, aged 69, suffered from severe pains in the limbs and joints but there was little if any swelling of the joints. The pains were severe and were not relieved by aspirin. Cinchophen was given to her in the Out-patient Department at first for three consecutive days and then when she comnplained of the return of the pains on the days on which she did not have the drug, it was given continuously. In the course of ten weeks she took 170 gr. a week, in addition to 150 gr. aspirin. At first she was better but after a time she lost her appetite and began to vomit. Later she became jaundiced and was then admitted into hospital. Cinchophen was taken until she was admitted into hospital. She was then very ill, deeply jaundiced. The stools contained some bile and the bilirubin in the blood gave an indirect test by Van den Bergh's reagent. She died on the eighth day after admission. The liver was small. Sir Bernard Spilsbury reported that there was advanced chronic hepatitis, with considerable destruction of the liver tissue. There were large areas in which the liver-tissue had completely disappeared, its place. having been taken by fibrous tissue with fibroblasts, and small round cells. The tissue was traversed by bile-ducts in large numbers, a few scattered atrophied cells being present. There were large numbers of liver-cells in all stages of necrosis and disintegration. A few haemorrhages were present. There was no multilobular cirrhosis and no obstruction in the bile-ducts.
Case II. Patient, a woman, aged 36, was suffering from a well-marked infective arthritis and was given the allyl ester ofcinchophen for a long time in varying doses. She was in hospital for five months and took about 2,000 gr. in the first threeimjonths and after a month's intermission she was given a further 330 gr. With one exception the drug was given every day in the week. She developed jaundice, and died some ten days after leaving hospital, and from Dr. N. S. Manning's description the symptoms were very similar to those of the other patient. No autopsy was obtained. 9 Case III.-C. Wells' patient, a woman, aged 63, had been taking atophan on her own account for a rheumatoid arthritis of some kind. She had about 150 gr. a week, taking some every day. She began to vomit occasionally after about three months but continued to take the drug as it relieved the joint-pains and she did not associate it with the vomiting. She went on taking it until three weeks before she died. Dr. Wells saw her on account of the vomiting some eight days before death. She became jaundiced four days later, and comatose two days later. The liver was very small, and a section by Dr. A. G. Gibson showed a severe chronic hepatitis.
There are four points which seem clear:-(1) It was not the same preparation which caused the symptoms, atophan being responsible for two fatal cases and phenoquin and atoquinol for one case each. In the non-fatal cases different preparations have also been used.
(2) The symptoms followed very different doses. In one case only 60 gr. of agotan were followed by jaundice. In two fatal cases 1,500 and 3,000 gr. had been taken before any symptoms occurred, while in the case of my male patient over 9,000 gr. a year have been taken in 6i years. The occurrence of symptoms after such various doses can only be explained on the grounds of an idiosyncracy. (3) In every case but one the drug was given every day of the week without any intermissions.
(4) In some of the patients there were deffnite signs of disturbance, but these were neglected.
The occurrence of a fatal jaundice following the prolonged use of cinchophen is very disturbing, and I bave investigated the state of three patients who have been taking it for some time, namely, the man who has been having it for 6i years, and two others. Dr. G. C. Linder has kindly made the following estimations for me.
In the case of the man the blood uric acid before the cinchophen was 5 mgm. per cent., and after three days' administration had fallen to 3 * 6 mgm. It is clear that he still needs cinchophen, and also that it has not lost its effect. The liver function was investigated by means of a dose of 25 grm. levulose on the first and fourth days after the cinchophen had been stopped. The graph ( fig. 5 ) shows that the two curves are very similar and that the rise in the blood-sugar is only 0 02 per cent., which is therefore quite normal.
Another patient, a woman, aged 55, has been taking cinchophen for nearly four years and has had two slight attacks of gout in this period. The blood uric acid was 2 * 8 mgm. before 10 Graham: The Treatment of Gout and 1*4 mgm. after the cinchophen. The lahvulose test, after 25 grm. (fig. 6 ), shows that the rise in the blood-sugar was 0 * 05 per cent. after 60 minims and such a rise is considered to be pathognomonic of liver disease. Three days later, however, the blood-sugar curve appeared quite normal, as the maximum rise which occurred after 40 minims was only 0 * 02 grm. per cent. Owing to a misunderstanding she had been taking the cinchophen until the last two months every other day instead of having a four days' rest between each course of treatment. It seems probable that this patient investigated has received some slight damage to the liver, but she remains perfectly well (December, 1926) . She seems to be having more cinchophen than is necessary, as the blood uric acid is now normal before the course of the cinchophen was given. In the case of a third woman the levulose curve was quite normal. What, then, is the lesson to be learnt from the occurrence of these three fatal cases of jaundice ? Should cinchophen be abandoned for the treatment of gout ? I should be very loth to suggest this as the results are so good in the great majority of cases. I would suggest, however, (1) that its use should be restricted mainly to gout patients. (2) That it should never be given for more than three or four days without giving a four days' rest. (3) That it would be an advantage to control the dosage by means of estimations of the blood uric acid, and if the figure becomes normal the dose can be reduced to two days a week, or even one day a week.
This completes my short survey of the treatment of gout, and in conclusion I would emphasize the importance of bearing in mind the possibility of any joint lesion being due to gout, because this is one of the few types of chronic arthritis which yield to treatment.
